Dr. David Fleischer completed his undergraduate training at the University of Pennsylvania in Philadelphia in 1992, medical degree training at Emory University School of Medicine in Atlanta in 1997, and both Pediatric Residency and Pediatric Allergy/Immunology Fellowship training at The Johns Hopkins University School of Medicine in Baltimore in 2005. Dr. Fleischer is currently the Associate Section Head of the Section of Allergy at Children’s Hospital Colorado (CHCO) and an Associate Professor of Pediatrics at CHCO and the University of Colorado Denver School of Medicine. Dr. Fleischer’s primary clinical interest is food allergy. His research has focused on the natural history of food allergy and novel treatments for food allergy, including oral, sublingual, and epicutaneous immunotherapies. He is the Global PI for the pivotal Phase III peanut epicutaneous immunotherapy trial that is being conducted at more than 30 sites across the world. He has been involved in several projects examining the primary prevention of allergy, including as a member of the 2015-16 National Institutes for Allergy and Infectious Diseases (NIAID) Expert Panel that updated the 2010 NIAID Food Allergy Guidelines on the topic of the Prevention of Peanut Allergy. He is Co-Director of the Food Challenge and Research Unit at CHCO, and he will co-direct the new Allergy and Immunology Center at CHCO when it opens in January 2018. Dr. Fleischer has authored many original, peer-reviewed articles, review articles, and book chapters on food allergy and food allergy treatment. He is the Chair for the AAAAI Adverse Reactions to Foods Committee and a Fellow of the AAAAI and the American College of Allergy, Asthma, and Immunology.